Targeting the PI3K/AKT/mTOR Signaling Axis in Children With Hematologic Malignancies

Paediatric Drugs - United Kingdom
doi 10.1007/bf03262236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC